These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 16445381)

  • 21. Detection of DNA copy number changes and oncogenic signaling abnormalities from gene expression data reveals MYC activation in high-grade papillary renal cell carcinoma.
    Furge KA; Chen J; Koeman J; Swiatek P; Dykema K; Lucin K; Kahnoski R; Yang XJ; Teh BT
    Cancer Res; 2007 Apr; 67(7):3171-6. PubMed ID: 17409424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prognostic factors in renal cell carcinoma].
    Letang N; Cabaniols L; Pouessel D; Robert M; Iborra F; Culine S; Patard JJ; Guiter J; Thuret R
    Bull Cancer; 2009 Apr; 96(4):475-84. PubMed ID: 19357021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of XIAP expression in renal cell carcinoma predicts a worse prognosis.
    Mizutani Y; Nakanishi H; Li YN; Matsubara H; Yamamoto K; Sato N; Shiraishi T; Nakamura T; Mikami K; Okihara K; Takaha N; Ukimura O; Kawauchi A; Nonomura N; Bonavida B; Miki T
    Int J Oncol; 2007 Apr; 30(4):919-25. PubMed ID: 17332931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Significance of Fas expression alteration during tumor progression of renal cell carcinoma.
    Sejima T; Miyagawa I
    Int J Urol; 2006 Mar; 13(3):257-64. PubMed ID: 16643620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD147 and VEGF expression in advanced renal cell carcinoma and their prognostic value.
    Liang YX; He HC; Han ZD; Bi XC; Dai QS; Ye YK; Qin WJ; Zeng GH; Zhu G; Xu CL; Zhong WD
    Cancer Invest; 2009 Aug; 27(7):788-93. PubMed ID: 19548138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic factors and selection for clinical studies of patients with kidney cancer.
    Lam JS; Klatte T; Kim HL; Patard JJ; Breda A; Zisman A; Pantuck AJ; Figlin RA
    Crit Rev Oncol Hematol; 2008 Mar; 65(3):235-62. PubMed ID: 17931881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evolving principles of surgical management and prognostic factors for outcome in renal cell carcinoma.
    Lam JS; Breda A; Belldegrun AS; Figlin RA
    J Clin Oncol; 2006 Dec; 24(35):5565-75. PubMed ID: 17158542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization and gene expression analysis of novel matched primary and metastatic renal cell carcinoma cell lines.
    Ohno Y; Izumi M; Tachibana M; Kawamura T; Yoshioka K; Aoyagi T; Ohori M; Namiki K; Sakamoto N; Nakagami Y; Hatano T; Akimoto S; Nishimura T
    Oncol Rep; 2008 Sep; 20(3):501-9. PubMed ID: 18695898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA.
    Urakami S; Shiina H; Enokida H; Hirata H; Kawamoto K; Kawakami T; Kikuno N; Tanaka Y; Majid S; Nakagawa M; Igawa M; Dahiya R
    Clin Cancer Res; 2006 Dec; 12(23):6989-97. PubMed ID: 17145819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A molecular classification of papillary renal cell carcinoma.
    Yang XJ; Tan MH; Kim HL; Ditlev JA; Betten MW; Png CE; Kort EJ; Futami K; Furge KA; Takahashi M; Kanayama HO; Tan PH; Teh BS; Luan C; Wang K; Pins M; Tretiakova M; Anema J; Kahnoski R; Nicol T; Stadler W; Vogelzang NG; Amato R; Seligson D; Figlin R; Belldegrun A; Rogers CG; Teh BT
    Cancer Res; 2005 Jul; 65(13):5628-37. PubMed ID: 15994935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene expression profiling of renal cell carcinoma: a DNA macroarray analysis.
    Lovisolo JA; Casati B; Clerici L; Marafante E; Bono AV; Celato N; Salvadore M
    BJU Int; 2006 Jul; 98(1):205-16. PubMed ID: 16831170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene expression in kidney cancer is associated with cytogenetic abnormalities, metastasis formation, and patient survival.
    Sültmann H; von Heydebreck A; Huber W; Kuner R; Buness A; Vogt M; Gunawan B; Vingron M; Füzesí L; Poustka A
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):646-55. PubMed ID: 15701852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic markers in renal cell carcinoma.
    Ljungberg B
    Curr Opin Urol; 2007 Sep; 17(5):303-8. PubMed ID: 17762621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Virtual-karyotyping with SNP microarrays in morphologically challenging renal cell neoplasms: a practical and useful diagnostic modality.
    Kim HJ; Shen SS; Ayala AG; Ro JY; Truong LD; Alvarez K; Bridge JA; Gatalica Z; Hagenkord JM; Gonzalez-Berjon JM; Monzon FA
    Am J Surg Pathol; 2009 Sep; 33(9):1276-86. PubMed ID: 19461508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [DNA and microRNA microarray technologies in diagnostics and prediction for patients with renal cell carcinoma].
    Slabý O; Svoboda M; Michálek J; Vyzula R
    Klin Onkol; 2009; 22(5):202-9. PubMed ID: 19886357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcription profiling of renal cell carcinoma.
    Huber W; Boer JM; von Heydebreck A; Gunawan B; Vingron M; Füzesi L; Poustka A; Sültmann H
    Verh Dtsch Ges Pathol; 2002; 86():153-64. PubMed ID: 12647365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accurate molecular classification of kidney cancer subtypes using microRNA signature.
    Youssef YM; White NM; Grigull J; Krizova A; Samy C; Mejia-Guerrero S; Evans A; Yousef GM
    Eur Urol; 2011 May; 59(5):721-30. PubMed ID: 21272993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular markers for predicting prognosis of renal cell carcinoma.
    Nogueira M; Kim HL
    Urol Oncol; 2008; 26(2):113-24. PubMed ID: 18312928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Molecular characterization of metastatic renal cell carcinomas. Differentiation of prognosis and therapy].
    Junker K; Sanjmyatav J; Heinze C; Walter M; Heinzelmann J; Wunderlich H; Schubert J; Steiner T
    Urologe A; 2008 Sep; 47(9):1187-9. PubMed ID: 18688592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of transcript for brain-type fatty Acid-binding protein in tumor and urine of patients with renal cell carcinoma.
    Teratani T; Domoto T; Kuriki K; Kageyama T; Takayama T; Ishikawa A; Ozono S; Nozawa R
    Urology; 2007 Feb; 69(2):236-40. PubMed ID: 17320655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.